J. Goldman & Co LP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,249,048
-20.5%
546,853
-1.0%
0.15%
-23.7%
Q2 2023$5,347,300
+702.5%
552,407
+808.6%
0.19%
+618.5%
Q1 2023$666,368
+122.9%
60,800
+350.4%
0.03%
+80.0%
Q3 2021$299,000
-79.1%
13,500
-86.1%
0.02%
-84.5%
Q3 2020$1,434,000
-64.3%
97,382
-60.6%
0.10%
-60.9%
Q2 2020$4,017,000
+87.5%
247,198
+67.5%
0.25%
-3.9%
Q1 2020$2,142,000
-30.7%
147,614
-3.2%
0.26%
+16.2%
Q4 2019$3,090,000152,5180.22%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders